Diagnostic delays and laboratory process inefficiencies constitute a common but unaddressed dilemma in contemporary healthcare, quietly undermining patient outcomes in metabolic and cardiovascular illnesses where immediate intervention is critical. This seminal work goes beyond traditional operational viewpoints to demonstrate diagnostic inefficiency as an independent, adjustable risk factor with far-reaching implications. We rigorously quantified the impact of delayed test processing and reporting on clinical outcomes using a comprehensive mixed-methods approach that included multi-center retrospective cohort analysis (N=128, 743 patients), real-time workflow mapping across 37 laboratories, in-depth case reviews, and economic modeling. Our findings challenged conventional wisdom by indicating that each 24-hour increase in diagnostic intervals increases the likelihood of 90-day death by 4. 7% (95% CI: 3. 9-5. 5%), outweighing standard clinical risk variables. Crucially, we observed non-linear damage thresholds: lipid panel delays of more than 72 hours decreased statin start by 41%, but 28-day diabetes diagnostic delays increased hyperglycemic crisis hospitalizations. Geospatial mapping revealed serious inequities, with rural patients enduring 2. 3 times longer waits than their urban counterparts, directly explaining 38% of outcome differences. The economic justification was similarly powerful, with a 5. 70 return on every dollar spent on laboratory optimization. Our results call for paradigm reforms, from establishing diagnostic efficiency as a primary quality indicator to deploying AI-driven scheduling, point-of-care testing methods, and mobile laboratory units in underserved locations. This study presents the ultimate evidence base and implementation toolbox for healthcare systems to reform diagnostic pathways, demonstrating that in cardio-metabolic care, minutes count, systems save lives, and equality in diagnosis is unavoidable.
Dzreke et al. (Wed,) studied this question.